This article was automatically translated from HIBAPRESS, the Arabic version:
Hibapress-Rabat-Oms
The four substances registered in Table I of the 1961 single convention on drugs, as modified by the 1972 protocol, are as follows:
The N-Pyrrolidino Protonitazène, also called protonitazepine, is a synthetic opioid. It is in the form of a beige powder or a white, colorless or crystalline solid, and has been identified in falsified pharmaceutical opioid tablets. It would be administered by various routes, being smoked, sniffed or injected. He can cause significant damage, including driving death. It has no known therapeutic use.
The N-Pyrrolidino metonitazen, also called metonitazepine, is a synthetic opioid. It is in the form of a beige powder and would be administered by injection. Conlint data show that its use causes significant damage, which can go as far as death. It has no known therapeutic use.
Etonitazépyne, also called n-piperidinyl etonitazène, is a synthetic opioid. It comes in the form of a crystalline solid or a yellow powder or a yellowish white. Conlint data show that the use of this substance causes significant damage, which can go as far as death. It has no known therapeutic use.
The isotonitazen n-eethyl, also called norisotonitazen, is a synthetic opioid which comes in the form of a crystalline solid. It has been identified in falsified pharmaceuticals. Many deaths and hospitalizations have been reported in at least two regions. Conlint data show that its use causes significant damage, which can go as far as death. It has no known therapeutic use.
Substance listed in Table II of the 1971 Convention on Psychotropic Substances:
Hexahydrocannabinol, also called HHC, is a semi-synthetic cannabinoid which is in the form of oil or colorless viscous resin. The HHC can be present in products such as flowers and cannabis resins infused or sprayed with substance, e-liquids and cartridges for electronic cigarettes, edible products such as gums and marshmallows, mother taints in food supplements and disilled oils. Sufficient evidence shows that the use of HHC is a public health problem and a social problem, justifying an investment under international control.
Substance registered in Table IV of the 1971 Convention on Psychotropic Substances:
Carisoprodol is a muscle relaxant with central action, sold in the form of a single ingredient preparation or in combination with other products. Carisoprodol is available in the form of pharmaceutical tablets; It has been detected in falsified pharmaceuticals and is also in the form of white powder. More and more convincing data show that the non -medical use of Carisoprodol in a number of countries is a significant risk for public health.
For more than 70 years, the WHO has brought together the Committee of Pharmacodependence Experts as a scientific advisory order whose mission is to protect populations from harmful substances and ensure that psychoactive substances are available where it is necessary for medical and scientific purposes. The Committee of Experts performs scientific examinations at the request of the United Nations drugs commission and it is the only body mandated by a treaty to provide health recommendations to the Commission in order to clarify decisions relating to policies in terms of psychoactive substances.
Given the constant emergence of harmful substances, including synthetic opioids made clandestinely and devoid of any medical use such as fentany and Nitaznes, Member States have expressed their interest in more scientific examinations of these substances by WHO in the future. The aforementioned decisions were announced during the sixty-eighth ordinary session of the drug of drugs, which was held in Vienna (Austria) from March 10 to 14, 2025.
